The impact of MTHFR 677 C/T genotypes on folate status markers: a meta-analysis of folic acid intervention studies

European Journal of Nutrition

Volumn 56, Issue 1, 2017, Pages 247-260

  Colson, Natalie J ^a,b   Naug, Helen L ^a,b   Nikbakht, Elham ^a,b   Zhang, Ping ^b   McCormack, Joanna ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Folate; Folic acid; Homocysteine; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE 677CC; METHYLENETETRAHYDROFOLATE REDUCTASE 677TT; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

AMINO ACID BLOOD LEVEL; ARTICLE; DIET SUPPLEMENTATION; FOLIC ACID BLOOD LEVEL; FORTIFIED FOOD; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; META ANALYSIS; PHARMACOGENETIC VARIANT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION; BLOOD; DIETARY SUPPLEMENT; FACTUAL DATABASE; GENETICS; NUTRITIONAL STATUS; OBSERVATIONAL STUDY;

BIOMARKERS; DATABASES, FACTUAL; DIETARY SUPPLEMENTS; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NUTRITIONAL STATUS; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84945162236     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-1076-x     Document Type: Article

References (80)

1. Peake JN, Copp AJ, Shawe J (2013) Knowledge and periconceptional use of folic acid for the prevention of neural tube defects in ethnic communities in the United Kingdom: systematic review and meta-analysis. Birth Defects Res A 97(7):444–451. doi:10.1002/bdra.23154
2. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ (2005) Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 113(5):825–828. doi:10.1002/ijc.20648
3. Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K (2011) Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer’s disease or dementia: a case control study. Eur Neurol 65(5):270–278. doi:10.1159/000326301
4. Gilbody S, Lightfoot T, Sheldon T (2007) Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 61(7):631–637. doi:10.1136/jech.2006.050385
5. Payne ME, Jamerson BD, Potocky CF, Ashley-Koch AE, Speer MC, Steffens DC (2009) Natural food folate and late-life depression. J Nutr Elder 28(4):348–358. doi:10.1080/01639360903417181
6. Wang ZM, Zhou B, Nie ZL, Gao W, Wang YS, Zhao H, Zhu J, Yan JJ, Yang ZJ, Wang LS (2012) Folate and risk of coronary heart disease: a meta-analysis of prospective studies. Nutri Metab Cardiovasc Dis NMCD 22(10):890–899. doi:10.1016/j.numecd.2011.04.011
7. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270(22):2693–2698
8. Wald DS, Wald NJ, Morris JK, Law M (2006) Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 333(7578):1114–1117. doi:10.1136/bmj.39000.486701.68
9. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354(15):1578–1588. doi:10.1056/NEJMoa055227
10. Brouwer IA, van Dusseldorp M, Thomas CM, Duran M, Hautvast JG, Eskes TK, Steegers-Theunissen RP (1999) Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 69(1):99–104
11. Shirodaria C, Antoniades C, Lee J, Jackson CE, Robson MD, Francis JM, Moat SJ, Ratnatunga C, Pillai R, Refsum H, Neubauer S, Channon KM (2007) Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation 115(17):2262–2270. doi:10.1161/CIRCULATIONAHA.106.679084
12. Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG, Scott JM (2002) Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 359(9302):227–228
13. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, Rosenberg IH (2007) A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomark Prev 16(7):1325–1329. doi:10.1158/1055-9965.EPI-07-0329
14. Johnson MA (2007) If high folic acid aggravates vitamin B12 deficiency what should be done about it? Nutr Rev 65(10):451–458
15. Krishnaveni GV, Veena SR, Karat SC, Yajnik CS, Fall CH (2014) Association between maternal folate concentrations during pregnancy and insulin resistance in Indian children. Diabetologia 57(1):110–121. doi:10.1007/s00125-013-3086-7
16. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, Bhat DS, Naik SS, Coyaji KJ, Joglekar CV, Joshi N, Lubree HG, Deshpande VU, Rege SS, Fall CH (2008) Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 51(1):29–38. doi:10.1007/s00125-007-0793-y
17. Bailey RL, Mills JL, Yetley EA, Gahche JJ, Pfeiffer CM, Dwyer JT, Dodd KW, Sempos CT, Betz JM, Picciano MF (2010) Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged ≥60 years in the United States. Am J Clin Nutr 92(2):383–389. doi:10.3945/ajcn.2010.29499
18. Obeid R, Kirsch SH, Dilmann S, Klein C, Eckert R, Geisel J, Herrmann W (2015) Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial. Eur J Nutr. doi:10.1007/s00394-015-0916-z
19. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, Selhub J, McTiernan A, Yasui Y, Oral E, Potter JD, Ulrich CM (2006) Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 136(1):189–194
20. Hirsch S, Miranda D, Munoz E, Montoya M, Ronco AM, de la Maza MP, Bunout D (2013) Natural killer cell cytotoxicity is not regulated by folic acid in vitro. Nutrition 29(5):772–776. doi:10.1016/j.nut.2012.10.006
21. Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q (2007) Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 109(7):3050–3059. doi:10.1182/blood-2006-07-034330
22. Ogino S, Wilson RB (2003) Genotype and haplotype distributions of MTHFR677C > T and 1298A > C single nucleotide polymorphisms: a meta-analysis. J Hum Genet 48(1):1–7. doi:10.1007/s100380300000
23. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B, Lin QR (1997) The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 17(6):1157–1162
24. Yang QH, Botto LD, Gallagher M, Friedman JM, Sanders CL, Koontz D, Nikolova S, Erickson JD, Steinberg K (2008) Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr 88(1):232–246
25. Yadav U, Kumar P, Yadav SK, Mishra OP, Rai V (2014) Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis. Metab Brain Dis. doi:10.1007/s11011-014-9575-7
26. To QG, Chen TT, Magnussen CG, To KG (2013) Workplace physical activity interventions: a systematic review. Am J Health Promot AJHP 27(6):e113–e123. doi:10.4278/ajhp.120425-LIT-222
27. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ (2005) Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 82(2):442–450
28. Hickling S, Hung J, Knuiman M, Jamrozik K, McQuillan B, Beilby J, Thompson P (2005) Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: a population based cohort study. J Epidemiol Community Health 59(5):371–376. doi:10.1136/jech.2004.027078
29. Williams LJ, Mai CT, Edmonds LD, Shaw GM, Kirby RS, Hobbs CA, Sever LE, Miller LA, Meaney FJ, Levitt M (2002) Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66(1):33–39. doi:10.1002/tera.10060
30. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee NS, Niyonsenga T (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357(2):135–142. doi:10.1056/NEJMoa067103
31. Mallard SR, Gray AR, Houghton LA (2012) Periconceptional bread intakes indicate New Zealand’s proposed mandatory folic acid fortification program may be outdated: results from a postpartum survey. BMC Pregnancy Childbirth 12:8. doi:10.1186/1471-2393-12-8
32. Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD (2007) Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001–2002. Am J Clin Nutr 85(5):1409–1416
33. Nagele P, Meissner K, Francis A, Fodinger M, Saccone NL (2011) Genetic and environmental determinants of plasma total homocysteine levels: impact of population-wide folate fortification. Pharmacogenet Genomics 21(7):426–431. doi:10.1097/FPC.0b013e32834741ff
34. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline (1998) Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. The National Academies Press, Washington DC
35. Solis C, Veenema K, Ivanov AA, Tran S, Li R, Wang W, Moriarty DJ, Maletz CV, Caudill MA (2008) Folate intake at RDA levels is inadequate for Mexican American men with the methylenetetrahydrofolate reductase 677TT genotype. J Nutr 138(1):67–72
36. Stamm RA, Houghton LA (2013) Nutrient intake values for folate during pregnancy and lactation vary widely around the world. Nutrients 5(10):3920–3947. doi:10.3390/nu5103920
37. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269
38. Ohrvik VE, Witthoft CM (2011) Human folate bioavailability. Nutrients 3(4):475–490. doi:10.3390/nu3040475
39. Homocysteine Lowering Trialists C (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82(4):806–812
40. Schorah CJ, Devitt H, Lucock M, Dowell AC (1998) The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study. Eur J Clin Nutr 52(6):407–411
41. Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ, Aitken W, Rossaak JI (2002) Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial. Eur J Clin Nutr 56(8):748–754. doi:10.1038/sj.ejcn.1601388
42. Hao L, Yang QH, Li Z, Bailey LB, Zhu JH, Hu DJ, Zhang BL, Erickson JD, Zhang L, Gindler J, Li S, Berry RJ (2008) Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial. Am J Clin Nutr 88(2):448–457
43. Bart S Sr, Marr J, Diefenbach K, Trummer D, Sampson-Landers C (2012) Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study. Contraception 85(1):42–50. doi:10.1016/j.contraception.2011.05.013
44. Alfthan G, Laurinen MS, Valsta LM, Pastinen T, Aro A (2003) Folate intake, plasma folate and homocysteine status in a random Finnish population. Eur J Clin Nutr 57(1):81–88. doi:10.1038/sj.ejcn.1601507
45. Australian Government Department of Health Nutrient Reference Values (2006). http://www.nrv.gov.au/home
46. European Food Safety Authority (2009) Folic acid: an update on scientific developments. 21–22 Jan 2009, Uppsala. ISBN: 978-92-9199-178-5
47. Ioannidis JP, Ntzani EE, Trikalinos TA (2004) ‘Racial’ differences in genetic effects for complex diseases. Nat Genet 36(12):1312–1318. doi:10.1038/ng1474
48. Higgins J, Deeks JJ, Altman DG (2008) Special topics in statistics. Cochrane handbook for systematic reviews of interventions: Cochrane book series, pp 481–529
49. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59(1):7–10. doi:10.1016/j.jclinepi.2005.06.006
50. Wong JY, Gilson ND, van Uffelen JG, Brown WJ (2012) The effects of workplace physical activity interventions in men: a systematic review. Am J Men’s Health 6(4):303–313. doi:10.1177/1557988312436575
51. Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG (2003) Evaluating non-randomised intervention studies. Health Technol Assess 7(27):1–173
52. Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. www.cochrane-handbook.org
53. Guinotte CL, Burns MG, Axume JA, Hata H, Urrutia TF, Alamilla A, McCabe D, Singgih A, Cogger EA, Caudill MA (2003) Methylenetetrahydrofolate reductase 677C–> T variant modulates folate status response to controlled folate intakes in young women. J Nutr 133(5):1272–1280
54. Zappacosta B, Mastroiacovo P, Persichilli S, Pounis G, Ruggeri S, Minucci A, Carnovale E, Andria G, Ricci R, Scala I, Genovese O, Turrini A, Mistura L, Giardina B, Iacoviello L (2013) Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia. Nutrients 5(5):1531–1543. doi:10.3390/nu5051531
55. Hiraoka M, Kato K, Saito Y, Yasuda K, Kagawa Y (2004) Gene–nutrient and gene–gene interactions of controlled folate intake by Japanese women. Biochem Biophys Res Commun 316(4):1210–1216. doi:10.1016/j.bbrc.2004.02.174
56. Ashfield-Watt PA, Pullin CH, Whiting JM, Clark ZE, Moat SJ, Newcombe RG, Burr ML, Lewis MJ, Powers HJ, McDowell IF (2002) Methylenetetrahydrofolate reductase 677C–> T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr 76(1):180–186
57. Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler J, Maneval DR, Quinlivan EP, Li Z, Bailey LB, Berry RJ (2011) MTHFR 677C–> T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am J Clin Nutr 93(6):1365–1372. doi:10.3945/ajcn.110.004671
58. Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, Guan D, Hu J, Wang Y, Zhang F, Xu X, Wang X, Huo Y (2012) Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses? Pharmacogenet Genomics 22(6):421–428. doi:10.1097/FPC.0b013e32834ac5e8
59. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers GH, Eskes TK (1998) Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 128(8):1336–1341
60. Miyaki K, Murata M, Kikuchi H, Takei I, Nakayama T, Watanabe K, Omae K (2005) Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype. J Hum Genet 50(5):241–248. doi:10.1007/s10038-005-0247-7
61. Fohr IP, Prinz-Langenohl R, Bronstrup A, Bohlmann AM, Nau H, Berthold HK, Pietrzik K (2002) 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr 75(2):275–282
62. Shelnutt KP, Kauwell GP, Chapman CM, Gregory JF 3rd, Maneval DR, Browdy AA, Theriaque DW, Bailey LB (2003) Folate status response to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677C–> T polymorphism in young women. J Nutri 133(12):4107–4111
63. Nakazato M, Maeda T, Emura K, Maeda M, Tamura T (2012) Blood folate concentrations analyzed by microbiological assay and chemiluminescent immunoassay methods. J Nutr Sci Vitaminol 58(1):59–62
64. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113. doi:10.1038/ng0595-111
65. Takeshima N, Sozu T, Tajika A, Ogawa Y, Hayasaka Y, Furukawa TA (2014) Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med Res Methodol 14:30. doi:10.1186/1471-2288-14-30
66. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
67. DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28(2):105–114. doi:10.1016/j.cct.2006.04.004
68. Liu CS, Chiang HC, Chen HW (2004) Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease. Nutrition 20(11–12):974–978. doi:10.1016/j.nut.2004.08.004
69. Kavvoura FK, Ioannidis JP (2008) Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet 123(1):1–14. doi:10.1007/s00439-007-0445-9
70. Trejaut JA, Poloni ES, Yen JC, Lai YH, Loo JH, Lee CL, He CL, Lin M (2014) Taiwan Y-chromosomal DNA variation and its relationship with Island Southeast Asia. BMC Genet 15:77. doi:10.1186/1471-2156-15-77
71. Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52(6):377–384
72. Guize L, Thomas F, Pannier B, Bean K, Danchin N, Benetos A (2006) [Metabolic syndrome: prevalence, risk factors and mortality in a French population of 62 000 subjects]. Bull Acad Natl Med 190(3):685–697 discussion 697–700
73. van Rosendal SP, Osborne MA, Fassett RG, Coombes JS (2010) Guidelines for glycerol use in hyperhydration and rehydration associated with exercise. Sports Med 40(2):113–139
74. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12
75. Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC, Li Z (2007) High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. J Nutr 137(2):407–413
76. Yang B, Fan S, Zhi X, Wang Y, Wang Y, Zheng Q, Sun G (2015) Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis. Nutrients 7(1):74–90. doi:10.3390/nu7010074
77. Li X, Jiang J, Xu M, Xu M, Yang Y, Lu W, Yu X, Ma J, Pan J (2015) Individualized supplementation of folic acid according to polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase reductase (MTRR) reduced pregnant complications. Gynecol Obstet Invest 79(2):107–112. doi:10.1159/000367656
78. Clinical Guideline (2014) Vitamin and mineral supplementation in pregnancy. Policy developed by: SA Maternal and Neonatal Clinical Network. Govt of South Australia. Approved 19 Dec 2014. https://www.sahealth.sa.gov.au/wps/wcm/connect/f53d44004eee83bc8104a36a7ac0d6e4/Vitamin+mineral+supplementation_Clinical+Guideline_final_Dec14.pdf?MOD=AJPERES&CACHEID=f53d44004eee83bc8104a36a7ac0d6e4
79. Bathum L, Petersen I, Christiansen L, Konieczna A, Sorensen TI, Kyvik KO (2007) Genetic and environmental influences on plasma homocysteine: results from a Danish twin study. Clin Chem 53(5):971–979. doi:10.1373/clinchem.2006.082149
80. Farrell CJ, Kirsch SH, Herrmann M (2013) Red cell or serum folate: what to do in clinical practice? Clin Chem Lab Med CCLM/FESCC 51(3):555–569. doi:10.1515/cclm-2012-0639